The three latest SMC decisions will provide new treatment options for some adults with non small cell lung cancer, multiple myeloma and a rare type of lymphoma.
A new targeted treatment has been recommended by the National Institute of Health and Care Excellence for some adults with ovarian cancer.
The Scottish Medicines Consortium (SMC) has approved a new chemotherapy-free treatment option for some adults with untreated chronic lymphocytic leukaemia.
The first chemotherapy-free drug combination for people with a rare type of bowel cancer has been approved for NHS use in England.
A new combination of targeted treatments will now be available for some adults with leukaemia on the NHS in England.
A new drug that has passed safety tests in adults is likely to be effective against the aggressive childhood cancer neuroblastoma.
A drug combination for people with a rare type of bowel cancer has received an initial rejection from the National Institute for Health and Care Excellence.
The National Institute for Health and Care Excellence has recommended a new combination therapy for adults with an aggressive type of non-Hodgkin lymphoma.
The targeted drug gilteritinib is now recommended for some adults with acute myeloid leukaemia (AML) on the NHS in England.